(-0.14%) 5 461.41 points
(-0.11%) 39 071 points
(0.10%) 17 736 points
(-0.67%) $80.29
(-4.32%) $2.64
(-0.77%) $2 312.90
(0.15%) $28.91
(2.36%) $1 009.70
(0.31%) $0.936
(0.74%) $10.68
(0.48%) $0.792
(-0.13%) $87.38
Live Chart Being Loaded With Signals
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for debilitating neurodegenerative diseases in Israel...
Stats | |
---|---|
Today's Volume | 50 |
Average Volume | 0 |
Market Cap | 15.25M |
EPS | $-0.190 ( Q4 | 2024-06-17 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.190 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
NeuroSense Therapeutics Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
NeuroSense Therapeutics Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-97 000.00 (0.00 %) |
EPS: | $-0.830 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-97 000.00 (0.00 %) |
EPS: | $-0.830 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-89 000.00 (0.00 %) |
EPS: | $-0.970 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
NeuroSense Therapeutics
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for debilitating neurodegenerative diseases in Israel. Its lead product candidate is PrimeC, a novel oral formulation for the treatment of amyotrophic lateral sclerosis. The company\'s preclinical pipeline product candidates include StabiliC for the treatment of Parkinson\'s disease; and CogniC for the treatment of Alzheimer\'s disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators